Entering text into the input field will update the search result below

Intersect ENT's (XENT) CEO Lisa Earnhardt on Q1 2018 Results - Earnings Call Transcript

May 01, 2018 8:39 PM ETMedtronic plc (MDT)
SA Transcripts profile picture
SA Transcripts

Intersect ENT Inc. (XENT) Q1 2018 Earnings Conference Call May 1, 2018 4:30 PM ET


Jeri Hilleman - Chief Financial Officer

Lisa Earnhardt - President and Chief Executive Officer


Chris Pasquale - Guggenheim

Kristen Stewart - Deutsche Bank

Ravi Misra - Barenberg Capital Markets

Kristen Stewart - Deutsche Bank


Good afternoon, and welcome to the Intersect ENT First Quarter 2018 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. Please note that this event is being recorded.

At this time, I’d now like to turn the conference call over to Jeri Hilleman, Chief Financial Officer. Please go ahead.

Jeri Hilleman

Thank you, Jeremy, and thank you all for participating on today’s call. Joining me today is Lisa Earnhardt, President and CEO.

Before we begin, I’d like to remind you that we will make forward-looking statements within the meaning of federal securities laws. Actual results and timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, our outlook for financial performance, sales force growth, clinical studies, approval of new products and indications and procurement of reimbursement codes and coverage, which are based upon our current estimates and assumptions as well as other risks detailed from time-to-time in the reports we file with the SEC. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein.

I’ll now turn the call over to Lisa Earnhardt. Lisa?

Lisa Earnhardt

Extraordinarily have been busy and exciting start to the year for our team delivering 21% topline growth and commencing the commercial launch of SINUVA. There were no surprises in our first quarter PROPEL in the result. We continue to deliver

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.